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This study was carried out to validate acclaimed anti-poliovirus effect of crude methanol extracts from 
14 medicinal plants used by traditional healers in Southwest Nigeria. Plant samples were powdered and 
extracted by cold maceration into absolute methanol and maximum non toxic concentration (MNTC) of 
each plant extract to rhabdomyosarcoma (RD) cells was determined in tissue culture. Using serial two-
fold dilution of the MNTC (specific for each extract), ability of extract to inhibit viral-induced cell death 
(CPE) in tissue culture was evaluated three days post-infection by 3-(4,5-Dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT) colorimetric assays. 50% inhibitory concentration (IC50) and 50% 
cytotoxic concentration (CC50) was determined by statistical analysis. Selective index was calculated as 
ratio of CC50 to IC50. Out of the 14 plant extracts evaluated for anti-poliovirus activity, Senna siamea 
(Lamk.) Irwin et Barneby (bark extract) and Zephyranthes candida Lindl (whole plant) demonstrated 
significant in vitro activity with IC50 of 0.0019 and 0.121 μg/mL, respectively. Bioassay-guided 
fractionation of extracts indicated that activities were retained in chloroform fraction of Z. candida, and 
also in hexane and chloroform fractions of S. siamea, but none of the polar fractions were active. These 
results support the traditional use of S. siamea and Z. candida as antiviral agents and suggest that they 
could provide a possible source for anti-poliovirus drug discovery and development. 
 





From the early times, plants have always been the basis 
of African traditional medicine. High reliance on medicinal 
plants and concurrent use of orthodox medicine for the 
treatment of infectious diseases is prevalent in Nigeria 
and in most African countries. The use of traditional 
medicine in Africa is widespread with an estimated 80% 
of the population consulting traditional healers. In addition 
to being accessible, the traditional healthcare system 
offers a cheaper, individualized and culturally acceptable 
alternative to the costly allopathic system (Eastman, 
2005). Infectious viral diseases still constitute a major 
threat to public health. This remains an important global 
challenge due to the fact that viruses have resisted pro-
phylaxis or therapy longer than any other form of life 
(Vanden Berghe et al., 1986). Viral resistance and viral 
latency leading to recurrent infections in immunocom-
promised patients have been some of the reasons for 
continuous search for newer antiviral drugs (Field and 
Biron, 1994; Severson et al., 1999; Khan et al., 2005). A 
wide range of ethnomedicinal plants showed strong anti-
viral activities either by inhibiting replication, or genome 
synthesis of many viruses (Semple et al., 2001; Kott et 
al., 1999; Mohamed et al., 2010). Hence, development of 
new antivirals from natural source is a strong alternate
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Plant extracts (part use
b
) Family MNTC (µg/ml) 
Crysophyllum albidum (s) Sapotaceae 10 
Khaya senegalensis (l) Meliaceae 1 
Khaya senegalensis (sb) Meliaceae 1 
Lippia multiflora (l) Verbenaceae 1 
Parquetina nigresence (rb) Periplocaceae 10 
Poga oleosa (f) Rhizophoraceae 10 
Senna siamea (sb) Fabaceae, Caesalpinioideae 1 
Sida acuta (w) Malvaceae 10 
Spondias mombin (sb)  Anacardiaceae 1 
Spondias mombin (l)  Anacardiaceae 1 
Tetrapleura teraptera (s) Mimosaceae 0.1 
Thoningia sanguinea (f) Balanophoraceae 10 
Uvaria chamae (sb)  Annonaceae 10 
Zephyranthes candida (w) Amaryllidaceae 0.1 
 





Poliomyelitis caused by the Poliovirus is a major cause 
of morbidity and mortality among children in developing 
countries. Polio eradication by vaccination of children in 
Nigeria has been largely unsuccessful due to the charac-
teristic problems of accessibility, limited supervision, 
cultural hindrances and occasional vaccine-associated 
paralytic poliomyelitis. The need to consider alternative 
ways of managing the infection becomes imperative.  
Ethnobotany has been described as a useful tool in 
selection of plants containing compounds active against 
viruses that cause human disease (Vlietinck and Vanden 
Berghe, 1991; Ajaiyeoba and Ogbole, 2005). This infor-
med our interest in carrying out an ethnobotanical survey 
in 4 local government areas in South-western Nigeria, 
which led to the identification of plants with potential 
antiviral activities (Ajaiyeoba et al., 2006). From the sur-
vey, 14 medicinal plants were selected for preliminary 
evaluation of anti-poliovirus activity. These were Sida 
acuta Burm.f. (Malvaceae) leaf, Thonningia sanguinea 
Vahl bulb, Chrysophyllum albidum G.Don  seed, Senna 
siamea (Lamk.) Irwin et Barneby leaf and  stem bark, 
Lippia multiflora (Moldenke) leaf, Zephyranthes candida 
Lindl whole plant, Parquetina nigrescens (Afzel. Bullock) 
root bark, Tetrapleura tetraptera (Schumach & Thonn) 
seed, Uvaria chamae (Beauv) bark, Poga oleosa. (Pierre) 
seed, Khaya senegalensis stem and bark, Spondias 
mombin (Linn) stem and bark (Ajaiyeoba et al., 2006). 
 
 
MATERIALS AND METHODS 
 
Cells and viruses 
 
Poliovirus Type-PV1 (Sabin strain) was obtained from stool isolate  
at the WHO Polio Laboratory, Department of Virology, University of 
Ibadan, Nigeria. Human Rhabdomysarcoma (RD) cells (CDC, 
Atlanta, Georgia) was used for both cytotoxic and antiviral studies. 
Cells were grown in Eagle’s minimum essential medium (MEM) 
supplemented with 10%  fetal bovine serum (FBS), 100 units/ml of 
penicillin, 100 μg/ml of streptomycin, 2 mM L-glutamine, 0.07% 
NaHCO3, and 1% non-essential amino acids and vitamin solution. 
The test medium used for cytotoxic assays and antiviral assays 
contained only 2 and 5% of fetal bovine serum. Virus titers were 
determined by cytopathic effect in RD cell and were expressed as 
50% tissue culture infective concentration (TCID50) per ml. All 
viruses were stored at −70°C until use. 
 
 
Plant materials collection, authentication and extraction 
 
Plants were selected based on frequency mentioned in the survey 
and availability. Stem bark and root bark as well as leaves were 
collected by staff of Forestry Research Institute of Nigeria (FRIN); 
seeds were bought from Oje market, Ibadan, Oyo State, Nigeria. Z. 
candida was collected from the grounds of the University College 
Hospital (UCH), Ibadan. Voucher specimens were identified by Mr. 
Seun Osiyemi at the herbarium of Forestry Research Institute of 
Nigeria (FRIN). Samples were deposited at the herbarium under 
various FHI numbers. The plants were sun-dried and ground to 
powdery forms. Each plant (400 g) was extracted by maceration in 
redistilled methanol for 72 h at room temperature (RT). Extracts 
were filtered and the solvents were evaporated using a rotary 
evaporator at 40°C. The dried extracts were stored in the refrigera-
tor at 4°C until needed for bioassay. The crude methanol extract of 
active plants was fractionated, using liquid-liquid extraction into 
hexane, chloroform, ethyl acetate and methanol. 
 
 
Preparation of extracts stock 
 
Crude extracts, 5 mg each were dissolved in dimethlysulfoxide 
(DMSO) and filtered through a sterile syringe filter (0.2 µm pore 
diameter)  to  give  a  concentration of 1 mg/ml stock; the stock was  
  




diluted to obtain a final concentration of 100 µg/ml (0.1% DMSO), 
designated as “neat”. 
 
 
Maximum non toxic concentration test of extracts 
 
This test was carried out to determine the maximum non toxic 
concentration test (MNTC) of crude extract to rhabdomyosarcoma 
cell in tissue culture. Serial ten-fold dilutions (100 to 0.001 µg/ml) of 
the extracts were made with maintenance medium. 96-wells plates 
previously seeded with monolayers of RD cells were treated with 
various concentrations of each extract. Plates were incubated at 
37°C in 5% CO2 humidified incubator for 72 h. Plates were then 
observed under the microscope for cell death/cytophatic effect 
(CPE). The minimum dilution of extracts with no toxic effect on the 
cells was referred to as maximum non toxic concentration. The 
maximum non-toxic concentration (MNTC) for an extract was the 
dilution of extract at which the microscopic examination, cells 
showed normal morphology and cell density in presence of extracts 
when compared to control cells grown without extract, and showed 
at least 95% of the optical density of the untreated cells as 
measured by a spectrophotometer at 540 nm (Multiscan 347, MTX 





The MTT colorimetric assay 
 
A tetrazolium yellow colorimetric assay was used to evaluate the 
reduction of viability of cell cultures with or without the extracts. The 
basic assay involved infection of cells culture with the virus in the 
presence of test compounds. The ability of the compounds to inhibit 
cell killing is measured  post-infection using MTT dye;  mitochon-
drial enzymes of viable cells convert MTT to a soluble, colored 
formazan product. The assay was carried out as earlier described 
by Mossmann (1983). 
 
 
Determination of cytotoxicity of extracts by MTT colorimetric 
assay 
 
After treatment with serial ten-fold dilutions (100 to 0.001 µg/ml) of 
each extract as described earlier, plates were incubated for 48 h at 
37°C. The medium was removed, and then 25 μl of MTT solution (5 
mg/ml) was added to each well and incubated for 2 h at 37°C. MTT 
solution was removed from the wells and 120 μl dimethylsulfoxide 
(DMSO) was added to dissolve insoluble formazan crystal. Optical 
density was measured spectrophotometrically (Multiscan 347, MTX 
lab) at 540 nm. Data obtained from quadruplicate wells was used to 




A - B 
% cytotoxicity =       ×  100 







Where, A is the mean optical density of untreated wells and B is the 
optical density of wells with plant extracts. 
 
 
Anti-poliovirus activity assay 
 
Inhibition of cytophatic effect (CPE): Neutralization assay 
 
Serial two-fold dilutions were made from MNTC of extracts-specific 





tenance medium to obtain 100 TCID50 per drop of 50 µl; to con-
fluent cell monolayers in a 96-well plate, serial two-fold dilutions of 
crude extracts were added and allowed to adsorb for 60 min at 
37°C, and 100 TCID50 (50% tissue culture-infective concentration) 
virus suspension was then added. For positive control, cells were 
infected with the same concentration of virus but without the addi-
tion of extract untreated cells (virus control), and as a negative or 
cell control, only maintenance medium was added to the cells 
(uninfected, untreated cell). The plates were incubated at 37°C in 
5% CO2 humidified incubator for 72 h. For the preliminary assay, 
plates were observed under the microscope for CPE. Scoring of 
wells was from 1+ to 4+ (25% to 100% of CPE). The concentration 
that reduced 50% of CPE with respect to the virus control was 
estimated from the statistical plots of the data and was defined as 
the 50% inhibitory concentration (IC50). 
Extracts and fractions from the two most active plants were 





Selective index, CC50 and IC50 
 
The 50% cytotoxic concentration (CC50) and the 50% inhibitory 
concentration (IC50) for each extract were calculated from concen-
tration-effect-curves after linear regression analysis. The selective 
index is defined as CC50 over IC50. It is the ratio given by the cyto-
toxic concentration divided by the inhibitory concentration. The 
selectivity index is a comparison of the amount of a test compound 





Preliminary antiviral screening 
 
Extracts of Z. candida and T. teraptera had the lowest 
maximum non-toxic concentration to RD cells in tissue 
culture medium with both of them having a concentration 
of 0.1 µg/ml. Result of the preliminary antiviral screening 
showed that only 3 out of the 14 crude plant extracts 
tested were active on poliovirus, inhibiting the cytophatic 
effect of the virus in tissue culture. Crude extract of Z. 
candida had 100% inhibition at 0.1 µg/ml, 75% at 0.05 
and 0.025 µg/ml. Extract of S. siamea also inhibited viral 
growth of 100% at 1 µg/ml, with 75% at 0.5 µg/ml and 
25% at 0.25 µg/ml. L. multiflora was active at its MNTC (1 
µg/ml) with 75% inhibition, slightly active at 0.5 µg/ml with 
25% inhibition. The result of the preliminary antiviral 





Data analysis with statistical program GraphPad Prism 
showed that the crude extract of Z. candida had CC50 
value of 0.2931 µg/ml, while its chloroform fraction from 
Z. candida had CC50 value of 0.1884 µg/ml; hexane, ethyl 
acetate and methanol fractions had very similar cytotoxic 
activity pattern with CC50 values of 27.5, 29.73 and 21.5
  








Plant extract Concentration (µg/mL) Percent inhibition 


























S. siamea extract/fraction MNTC (µg) CC50 (µg/ml) IC50 (µg/ml) SI 
Crude 1 2.96 0.121 24.4 
Chloroform 10 39.24 0.227 172.8 
Ethyl acetate 10 13.49 3.41 3.90 
Hexane 10 12.52 0.507 24.5 
Methanol 100 172.1 17.94 9.60 
 
Cytotoxic and anti-poliovirus activity were determined by MTT assay. MNTC = maximum non toxic concentration; CC50 








Z. candida extract/ fraction MNTC (µg) CC50 (µg/ml) IC50 (µg/ml) SI 
Crude 0.1 0.293 0.0019 157.80 
Chloroform 0.1 0.188 
1
 0.0012 157.60 
Ethyl acetate 10 27.50 3.78 7.30 
Hexane 10 29.73 1.62 18.30 
Methanol 10 21.50 6.36 3.38 
 
Cytotoxic and anti-poliovirus activity were determined by MTT assay. MNTC = maximum non toxic concentration; CC50 




µg/ml, respectively.  
The CC50 value of crude extract of S. siamea was 2.958 
µg/ml, while its fractions showed a wide range of cyto-
toxic activity; hexane fraction and ethyl acetate fraction 
had CC50 value of 12.52 and 13.49 µg/ml, respectively; 
chloroform 39.24 µg/ml; methanol fraction is the least 
toxic with 172.1 µg/ml. 
Anti-poliovirus activity 
 
Results obtained indicate that crude extract of Z. candida 
had IC50 value of 0.0019μg/ml while the crude extract of 
S. siamea had IC50 value of 0.21
 
µg/ml as shown in 
Tables 3 and 4. The chloroform fraction of Z. candida 
was  most active with of all the fractions with IC50 value of  
  




0.0012 µg/ml; it was also more active compared to the 
crude extract. Chloroform fractions of S. siamea was the 
most active fraction with IC50 value of 0.227
 
µg/ml, and 
the hexane fraction was also active with IC50 value of 
0.507 µg/ml. The methanol fraction was not very active 
compared to the other fraction. All extracts/fraction showed 
agreeable correlation coefficient (R
2
) values (a correlation 
coefficient R
2 
of +1 indicates that two variables are 
perfectly related in a positive linear sense, in this case it 
means that the activity of extracts/fraction perfectly relate 
to concentration in a positive way). Selective indices 





Despite the popular use of medicinal plants preparations 
in several parts of the world, individually or in combina-
tion, report about their interactions on the living system is 
scarce; ethnobotanical studies have been shown to be a 
useful guide to the selection of plants containing com-
pounds active against viruses that cause human disease 
(Vlietinck and Vanden Berghe, 1991). Out of 14 medicinal 
plants screened, three, namely; Z. candida, S. siamea 
and L. multiflora were active on poliovirus. The two most 
active plant; Z. candida and S. siamea were selected for 
further screening while L. multiflora was not fractionated 
since it was only active in one subsequent dilution of the 
maximum non-toxic concentration.  
Vanden Berghe et al. (1993) suggested that for a plant 
extract to be considered active; the antiviral activity of 
crude plant extracts should be detectable in at least two 
subsequent dilutions of the maximum non-toxic concen-
tration, to ensure that the activity is not directly correlated 
with the toxicity of the extract. Z. candida belongs to the 
Amaryllidaceae family, a family of bulbous plant, which 
has long been known for their medicinal and toxic 
properties (Bastida et al., 1998).  
Some plants of the Amaryllidaceae have been used in 
the primitive treatment of human cancer, and a variety of 
tumor inhibiting alkaloids has been isolated from 
Zephyranthes species, (Kojima et al., 1998). Its antitumor 
activity in this study might be due to the presence of 
some tumor inhibiting alkaloids widely distributed in the 
Zephyranthes species. It has been shown that, it is 
possible for the crude extract to exhibit more biological 
activity than the fractions; this is usually attributable to 
synergistic activity of compounds present in the plant 
(Amoros et al., 1992). 
The cytotoxic activity of crude extract of S. siamea was 
observed to be greater than its fractions (Table 3); thus 
suggesting the possibility of synergistic effect of the 
extracts. All extracts/fractions of the two plants were sig-
nificantly active on poliovirus and results obtained were 





The chloroform fraction of Z. candida with IC50 value of 
0.0012 μg/ml, chloroform and hexane fraction of S. 
siamea with IC50 value of 0.227 and 0.507 μg/ml, res-
pectively demonstrated the highest degree of anti-
poliovirus activity, which led to the conclusion that the 
antiviral property of both plants resides in their medium to 
low polarity fractions. The cytotoxicity evaluation of the 
extracts and fractions corresponds directly to their anti-
viral activities. Ethanol extracts of K. senegalensis was 
earlier reported to have anti-poliovirus activity (Kudi and 
Myint, 1999); this is at variance with the findings in this 
study.  
This may be attributed to the different cell line used. 
Hudson (1990) reported that variation in activity is directly 
related to cell types used. In contrast to earlier results 
reported by Ananil et al. (2000), L. multiflora demonstra-
ted slight anti-poliovirus activity. This is probably due to 
low levels of antiviral compounds in the extract in a non-
cytotoxic dilution. The cell cytotoxic concentrations (CC50) 
of crude extract, hexane and chloroform fractions of S. 
siamea were several magnitudes higher than the effect-
tive concentrations inhibiting CPE by 50% (IC50), indica-
ting that this extracts were relatively non-toxic (SI, bet-
ween 24.4 and 172.8), while the ethyl acetate and metha-
nol fractions are highly toxic (low safety margin) and are 
not considered to be good fractions for antiviral use. Only 
the crude extracts and chloroform fraction of Z. candida 
showed acceptable therapeutic margin (≥1, the higher the 
therapeutic margin the safer the drug). 
Kudi and Myint (1999) reported the antipoliovirus 
activity of some Nigerian medicinal plants which includes; 
Bauhinia thonningii, Cassia goratensis, Anacardium 
occidentale, Butyrospermum parkii, Boswelia dalzielii, K. 
senegalensis, while there has been no previous report on 
the anti-poliovirus activity of S. siamea and Z. candida 





Ethnomedicine and ethnobotany have presented them-
selves as viable tools for drug discovery, this is more 
evident in this study as the two active plants, Z. candida 
and S. siamea were selected from an earlier ethnobotani-
cal survey. Work is presently being undertaken to isolate 
and identify the antiviral components of these active 
extracts. It is possible that the elucidation of the active 
constituents in these plants may provide useful leads in 





Ajaiyeoba EO, and Ogbole OO (2005). A phytotherapeutic approach to 
anti-HIV and immunomodulatory drug discovery from Nigeria 






Ajaiyeoba, EO, Ogbole OO, Ogundipe OO (2006). Ethnobotanical 
Survey of Plants used in the Traditional Management of Viral 
Infections in Ogun State of Nigeria. Eur. J. of Sci. Res. 13 (1): 64-73. 
Amoros M, Simoes CM, Girre L, Sauvager F, Cormier M (1992). 
Synergistic effect of flavones and flavonols against herpes simplex 
virus type 1 in cell culture. Comparison with the antiviral activity of 
propolis. J. Nat Prod. 55:1732–1740. 
Ananil K, Hudson JB, de Souza C, Akpaganal K, Tower GHN, Amason 
JT, Gbeassor M(2000). Investigation of medicinal plants of Togo for 
antiviral and antimicrobial activities.  Pharm. Biol. 38(1):40-45. 
Bastida J, Viladomat F, Bergonon S, Fernandez JM, Codina C, 
Rubiralta M, Quirion JC(1998). Alkaloids from Narcissus leonensis, 
Phytochem. 34:1656-1658.  
Chattopadhyay D (2006) Role and Scope of Ethnomedical Plants in the 
Development of Antivirals Pharmacology online 3: 64-72. 
Eastman  R (2005). Epilepsy in South Africa. Acta Neurolica Scand. 
112:8–11. 
Field AK, Biron KK (1994). The end of innocence revisited: Resistance 
of herpes viruses to antiviral drugs. Clin Microbiol. Rev. 7:1-13.  
Hudson JB (1990) Antiviral Compounds from Plants. Boca Raton, Ann 
Arbor, Boston: CRC Press. 
Khan  MT,  Ather  A,  Thompson  KD,  Gambari  R (2005).  Extracts and 
molecules from medicinal  plants  against  herpes  simplex viruses. 
Antiviral Res. 67:107-19  
Kojima TI, Motoh M, Makoto I, Yukio O (1998). Two Alkaloids from 
Zephyranthes Carina.  Phytochem. 48(7):1199-1202.  
Kott V, Barbini L, Cruanes M, Munoz JD, Vivot E, Cruanes J, Martino V, 























Kudi AC, Myint SH (1999). Antiviral activity of some Nigerian medicinal 
plant extracts, J. Ethnopharmacol, 68:289–294. 
Mossman T (1983). Rapid colorimetric assay for cellular growth and 
survival: application to proliferation and cytotoxicity assays, J. 
Immunol. Meth. 65:55–63. 
Semple SJ, Pyke S M, Reynolds GD, Robert LP (2001). In vitro antiviral 
activity of the anthraquinone chrysophanic acid against poliovirus 
Antiviral Res. 49:169–178 
Severson  JL,  Tyring  SK (1999). Relation  between  herpes  simplex 
viruses  and  human  immunodeficiency  virus  infections. Arch 
Dermatol. 135:1393-7.  
Vanden Berghe DA, Vlietinck AJ, Van Hoof L (1986). Plant products as 
potential antiviral agents. Bull. de L’Inst. Past. 84:101–107. 
Vanden Berghe  DA, Haemers, A, Vlietinck AJ (1993). Antiviral agents 
from higher plants and an example of structure-activity relationship of 
3-methoxyflavones. In: Colegate  SM, Molyneux  RJ (Eds.), Bioactive 
Natural Products. Detection, Isolation, and Structural Determination. 
CRC Press, Boca Raton, 405–440. 
Vlietinck AJ, Vanden Berghe DA (1991). Can ethnopharmacology 
contribute to the development of antiviral drugs? J. Ethnopharmacol. 
32:141–15. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
